Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 446

1.

Quantitative and functional profiles of CD4+ lymphocyte subsets in systemic lupus erythematosus patients with lymphopenia.

Gómez-Martín D, Díaz-Zamudio M, Vanoye G, Crispín JC, Alcocer-Varela J.

Clin Exp Immunol. 2011 Apr;164(1):17-25. doi: 10.1111/j.1365-2249.2010.04309.x. Epub 2011 Jan 14.

2.

Quantitative and qualitative deficiencies of regulatory T cells in patients with systemic lupus erythematosus (SLE).

Bonelli M, Savitskaya A, von Dalwigk K, Steiner CW, Aletaha D, Smolen JS, Scheinecker C.

Int Immunol. 2008 Jul;20(7):861-8. doi: 10.1093/intimm/dxn044. Epub 2008 May 9.

PMID:
18469329
3.

CD4(+)CD25 (+) regulatory T cells in human lupus erythematosus.

Kuhn A, Beissert S, Krammer PH.

Arch Dermatol Res. 2009 Jan;301(1):71-81. doi: 10.1007/s00403-008-0891-9. Epub 2008 Nov 5. Review.

PMID:
18985367
4.

The circulating lymphocyte profiles in patients with discoid lupus erythematosus and systemic lupus erythematosus suggest a pathogenetic relationship.

Wouters CH, Diegenant C, Ceuppens JL, Degreef H, Stevens EA.

Br J Dermatol. 2004 Apr;150(4):693-700.

PMID:
15099365
5.

Reduction of forkhead box P3 levels in CD4+CD25high T cells in patients with new-onset systemic lupus erythematosus.

Zhang B, Zhang X, Tang F, Zhu L, Liu Y.

Clin Exp Immunol. 2008 Aug;153(2):182-7. doi: 10.1111/j.1365-2249.2008.03686.x. Epub 2008 May 26.

6.

Enrichment of CD4+ CD25high T cell population in patients with systemic lupus erythematosus treated with glucocorticoids.

Suárez A, López P, Gómez J, Gutiérrez C.

Ann Rheum Dis. 2006 Nov;65(11):1512-7. Epub 2006 Apr 10.

7.

Dysfunctional CD4+,CD25+ regulatory T cells in untreated active systemic lupus erythematosus secondary to interferon-alpha-producing antigen-presenting cells.

Yan B, Ye S, Chen G, Kuang M, Shen N, Chen S.

Arthritis Rheum. 2008 Mar;58(3):801-12. doi: 10.1002/art.23268.

8.

Patients with Systemic Lupus Erythematosus Show Increased Levels and Defective Function of CD69+ T Regulatory Cells.

Vitales-Noyola M, Oceguera-Maldonado B, Niño-Moreno P, Baltazar-Benítez N, Baranda L, Layseca-Espinosa E, Abud-Mendoza C, González-Amaro R.

Mediators Inflamm. 2017;2017:2513829. doi: 10.1155/2017/2513829. Epub 2017 Sep 6.

9.

Clinical significance of increased CD4+CD25-Foxp3+ T cells in patients with new-onset systemic lupus erythematosus.

Zhang B, Zhang X, Tang FL, Zhu LP, Liu Y, Lipsky PE.

Ann Rheum Dis. 2008 Jul;67(7):1037-40. doi: 10.1136/ard.2007.083543. Epub 2008 Jan 16.

PMID:
18199598
10.

Altered homeostasis of CD4(+) FoxP3(+) regulatory T-cell subpopulations in systemic lupus erythematosus.

Suen JL, Li HT, Jong YJ, Chiang BL, Yen JH.

Immunology. 2009 Jun;127(2):196-205. doi: 10.1111/j.1365-2567.2008.02937.x. Epub 2008 Sep 16.

11.

The quantitative analysis of peripheral blood FOXP3-expressing T cells in systemic lupus erythematosus and rheumatoid arthritis patients.

Lin SC, Chen KH, Lin CH, Kuo CC, Ling QD, Chan CH.

Eur J Clin Invest. 2007 Dec;37(12):987-96.

PMID:
18036033
12.

Are CD4+CD25-Foxp3+ cells in untreated new-onset lupus patients regulatory T cells?

Yang HX, Zhang W, Zhao LD, Li Y, Zhang FC, Tang FL, He W, Zhang X.

Arthritis Res Ther. 2009;11(5):R153. doi: 10.1186/ar2829. Epub 2009 Oct 12.

13.

Regulatory T cells in patients with systemic lupus erythematosus.

Alvarado-Sánchez B, Hernández-Castro B, Portales-Pérez D, Baranda L, Layseca-Espinosa E, Abud-Mendoza C, Cubillas-Tejeda AC, González-Amaro R.

J Autoimmun. 2006 Sep;27(2):110-8. Epub 2006 Aug 4.

PMID:
16890406
14.

CD4+CD25+ regulatory T cells (TREG) in systemic lupus erythematosus (SLE) patients: the possible influence of treatment with corticosteroids.

Azab NA, Bassyouni IH, Emad Y, Abd El-Wahab GA, Hamdy G, Mashahit MA.

Clin Immunol. 2008 May;127(2):151-7. doi: 10.1016/j.clim.2007.12.010. Epub 2008 Mar 4.

PMID:
18299252
15.

T-regs in autoimmune hepatitis-systemic lupus erythematosus/mixed connective tissue disease overlap syndrome are functionally defective and display a Th1 cytokine profile.

Longhi MS, Ma Y, Grant CR, Samyn M, Gordon P, Mieli-Vergani G, Vergani D.

J Autoimmun. 2013 Mar;41:146-51. doi: 10.1016/j.jaut.2012.12.003. Epub 2013 Jan 1.

PMID:
23287048
16.

Phenotypic and functional analysis of CD4+ CD25- Foxp3+ T cells in patients with systemic lupus erythematosus.

Bonelli M, Savitskaya A, Steiner CW, Rath E, Smolen JS, Scheinecker C.

J Immunol. 2009 Feb 1;182(3):1689-95.

17.

Unmasking of autoreactive CD4 T cells by depletion of CD25 regulatory T cells in systemic lupus erythematosus.

Engler JB, Undeutsch R, Kloke L, Rosenberger S, Backhaus M, Schneider U, Egerer K, Dragun D, Hofmann J, Huscher D, Burmester GR, Humrich JY, Enghard P, Riemekasten G.

Ann Rheum Dis. 2011 Dec;70(12):2176-83. doi: 10.1136/ard.2011.153619. Epub 2011 Sep 16.

PMID:
21926188
18.

Increased interleukin-23 receptor(+) T cells in peripheral blood mononuclear cells of patients with systemic lupus erythematosus.

Puwipirom H, Hirankarn N, Sodsai P, Avihingsanon Y, Wongpiyabovorn J, Palaga T.

Arthritis Res Ther. 2010;12(6):R215. doi: 10.1186/ar3194. Epub 2010 Nov 29.

19.

CD134 expression on CD4+ T cells is associated with nephritis and disease activity in patients with systemic lupus erythematosus.

Patschan S, Dolff S, Kribben A, Dürig J, Patschan D, Wilde B, Specker C, Philipp T, Witzke O.

Clin Exp Immunol. 2006 Aug;145(2):235-42.

20.

Defective response of CD4(+) T cells to retinoic acid and TGFβ in systemic lupus erythematosus.

Sobel ES, Brusko TM, Butfiloski EJ, Hou W, Li S, Cuda CM, Abid AN, Reeves WH, Morel L.

Arthritis Res Ther. 2011 Jun 27;13(3):R106. doi: 10.1186/ar3387.

Supplemental Content

Support Center